214 related articles for article (PubMed ID: 8485049)
1. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer.
Gastl G; Plante M; Finstad CL; Wong GY; Federici MG; Bander NH; Rubin SC
Br J Haematol; 1993 Mar; 83(3):433-41. PubMed ID: 8485049
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.
Hsu HC; Tsai WH; Jiang ML; Ho CH; Hsu ML; Ho CK; Wang SY
J Lab Clin Med; 1999 Oct; 134(4):392-7. PubMed ID: 10521086
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis.
Hollen CW; Henthorn J; Koziol JA; Burstein SA
Br J Haematol; 1991 Oct; 79(2):286-90. PubMed ID: 1958487
[TBL] [Abstract][Full Text] [Related]
4. Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.
van der Zee AG; de Cuyper EM; Limburg PC; de Bruijn HW; Hollema H; Bijzet J; Krans M; de Vries EG
Cancer; 1995 Feb; 75(4):1004-9. PubMed ID: 7842401
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.
Plante M; Rubin SC; Wong GY; Federici MG; Finstad CL; Gastl GA
Cancer; 1994 Apr; 73(7):1882-8. PubMed ID: 8137215
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of thrombocytosis in ovarian cancer.
Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
[TBL] [Abstract][Full Text] [Related]
7. Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.
Gastl G; Plante M
Methods Mol Med; 2001; 39():121-3. PubMed ID: 21340762
[TBL] [Abstract][Full Text] [Related]
8. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
[TBL] [Abstract][Full Text] [Related]
9. Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients.
Bozkurt N; Yuce K; Basaran M; Gariboglu S; Kose F; Ayhan A
Int J Gynecol Cancer; 2006; 16(1):83-6. PubMed ID: 16445615
[TBL] [Abstract][Full Text] [Related]
10. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-10 in patients with ovarian carcinoma.
Mustea A; Könsgen D; Braicu EI; Pirvulescu C; Sun P; Sofroni D; Lichtenegger W; Sehouli J
Anticancer Res; 2006; 26(2C):1715-8. PubMed ID: 16617566
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic thrombocytosis in ovarian cancer.
Stone RL; Nick AM; McNeish IA; Balkwill F; Han HD; Bottsford-Miller J; Rupairmoole R; Armaiz-Pena GN; Pecot CV; Coward J; Deavers MT; Vasquez HG; Urbauer D; Landen CN; Hu W; Gershenson H; Matsuo K; Shahzad MM; King ER; Tekedereli I; Ozpolat B; Ahn EH; Bond VK; Wang R; Drew AF; Gushiken F; Lamkin D; Collins K; DeGeest K; Lutgendorf SK; Chiu W; Lopez-Berestein G; Afshar-Kharghan V; Sood AK
N Engl J Med; 2012 Feb; 366(7):610-8. PubMed ID: 22335738
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis.
Estrov Z; Talpaz M; Mavligit G; Pazdur R; Harris D; Greenberg SM; Kurzrock R
Am J Med; 1995 Jun; 98(6):551-8. PubMed ID: 7539977
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.
Santin AD; Bellone S; Ravaggi A; Roman J; Smith CV; Pecorelli S; Cannon MJ; Parham GP
BJOG; 2001 Aug; 108(8):804-8. PubMed ID: 11510703
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma.
Xie X; Ye D; Chen H; Lu W; Cheng B; Zhong H
Int J Gynaecol Obstet; 2004 May; 85(2):151-8. PubMed ID: 15099777
[TBL] [Abstract][Full Text] [Related]
16. Significance of thrombocytosis in patients with epithelial ovarian cancer.
Zeimet AG; Marth C; Müller-Holzner E; Daxenbichler G; Dapunt O
Am J Obstet Gynecol; 1994 Feb; 170(2):549-54. PubMed ID: 8116711
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
[TBL] [Abstract][Full Text] [Related]
18. Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients.
Hurteau JA; Simon HU; Kurman C; Rubin L; Mills GB
Am J Obstet Gynecol; 1994 Mar; 170(3):918-28. PubMed ID: 8141226
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-6 levels in patients with thrombocytosis.
Hollen CW; Henthorn J; Koziol JA; Burstein SA
Leuk Lymphoma; 1992 Oct; 8(3):235-41. PubMed ID: 1490150
[TBL] [Abstract][Full Text] [Related]
20. Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival.
Menczer J; Schejter E; Geva D; Ginath S; Zakut H
Eur J Gynaecol Oncol; 1998; 19(1):82-4. PubMed ID: 9476067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
